TU Darmstadt / ULB / TUbiblio

Roadmap: helium ion therapy

Mairani, Andrea ; Mein, Stewart ; Blakely, Eleanor ; Debus, Jürgen ; Durante, Marco ; Ferrari, Alfredo ; Fuchs, Hermann ; Georg, Dietmar ; Grosshans, David R. ; Guan, Fada ; Haberer, Thomas ; Harrabi, Semi ; Horst, Felix ; Inaniwa, Taku ; Karger, Christian P. ; Mohan, Radhe ; Paganetti, Harald ; Parodi, Katia ; Sala, Paola ; Schuy, Christoph ; Tessonnier, Thomas ; Titt, Uwe ; Weber, Ulrich (2022)
Roadmap: helium ion therapy.
In: Physics in Medicine & Biology, 2022, 67 (15)
doi: 10.26083/tuprints-00021906
Artikel, Zweitveröffentlichung, Verlagsversion

WarnungEs ist eine neuere Version dieses Eintrags verfügbar.

Kurzbeschreibung (Abstract)

Helium ion beam therapy for the treatment of cancer was one of several developed and studied particle treatments in the 1950s, leading to clinical trials beginning in 1975 at the Lawrence Berkeley National Laboratory. The trial shutdown was followed by decades of research and clinical silence on the topic while proton and carbon ion therapy made debuts at research facilities and academic hospitals worldwide. The lack of progression in understanding the principle facets of helium ion beam therapy in terms of physics, biological and clinical findings persists today, mainly attributable to its highly limited availability. Despite this major setback, there is an increasing focus on evaluating and establishing clinical and research programs using helium ion beams, with both therapy and imaging initiatives to supplement the clinical palette of radiotherapy in the treatment of aggressive disease and sensitive clinical cases. Moreover, due its intermediate physical and radio-biological properties between proton and carbon ion beams, helium ions may provide a streamlined economic steppingstone towards an era of widespread use of different particle species in light and heavy ion therapy. With respect to the clinical proton beams, helium ions exhibit superior physical properties such as reduced lateral scattering and range straggling with higher relative biological effectiveness (RBE) and dose-weighted linear energy transfer (LETd) ranging from ∼4 keV μm⁻¹ to ∼40 keV μm⁻¹. In the frame of heavy ion therapy using carbon, oxygen or neon ions, where LETd increases beyond 100 keV μm⁻¹, helium ions exhibit similar physical attributes such as a sharp lateral penumbra, however, with reduced radio-biological uncertainties and without potentially spoiling dose distributions due to excess fragmentation of heavier ion beams, particularly for higher penetration depths. This roadmap presents an overview of the current state-of-the-art and future directions of helium ion therapy: understanding physics and improving modeling, understanding biology and improving modeling, imaging techniques using helium ions and refining and establishing clinical approaches and aims from learned experience with protons. These topics are organized and presented into three main sections, outlining current and future tasks in establishing clinical and research programs using helium ion beams—A. Physics B. Biological and C. Clinical Perspectives.

Typ des Eintrags: Artikel
Erschienen: 2022
Autor(en): Mairani, Andrea ; Mein, Stewart ; Blakely, Eleanor ; Debus, Jürgen ; Durante, Marco ; Ferrari, Alfredo ; Fuchs, Hermann ; Georg, Dietmar ; Grosshans, David R. ; Guan, Fada ; Haberer, Thomas ; Harrabi, Semi ; Horst, Felix ; Inaniwa, Taku ; Karger, Christian P. ; Mohan, Radhe ; Paganetti, Harald ; Parodi, Katia ; Sala, Paola ; Schuy, Christoph ; Tessonnier, Thomas ; Titt, Uwe ; Weber, Ulrich
Art des Eintrags: Zweitveröffentlichung
Titel: Roadmap: helium ion therapy
Sprache: Englisch
Publikationsjahr: 2022
Ort: Darmstadt
Publikationsdatum der Erstveröffentlichung: 2022
Verlag: IOP Publishing
Titel der Zeitschrift, Zeitung oder Schriftenreihe: Physics in Medicine & Biology
Jahrgang/Volume einer Zeitschrift: 67
(Heft-)Nummer: 15
Kollation: 62 Seiten
DOI: 10.26083/tuprints-00021906
URL / URN: https://tuprints.ulb.tu-darmstadt.de/21906
Zugehörige Links:
Herkunft: Zweitveröffentlichung DeepGreen
Kurzbeschreibung (Abstract):

Helium ion beam therapy for the treatment of cancer was one of several developed and studied particle treatments in the 1950s, leading to clinical trials beginning in 1975 at the Lawrence Berkeley National Laboratory. The trial shutdown was followed by decades of research and clinical silence on the topic while proton and carbon ion therapy made debuts at research facilities and academic hospitals worldwide. The lack of progression in understanding the principle facets of helium ion beam therapy in terms of physics, biological and clinical findings persists today, mainly attributable to its highly limited availability. Despite this major setback, there is an increasing focus on evaluating and establishing clinical and research programs using helium ion beams, with both therapy and imaging initiatives to supplement the clinical palette of radiotherapy in the treatment of aggressive disease and sensitive clinical cases. Moreover, due its intermediate physical and radio-biological properties between proton and carbon ion beams, helium ions may provide a streamlined economic steppingstone towards an era of widespread use of different particle species in light and heavy ion therapy. With respect to the clinical proton beams, helium ions exhibit superior physical properties such as reduced lateral scattering and range straggling with higher relative biological effectiveness (RBE) and dose-weighted linear energy transfer (LETd) ranging from ∼4 keV μm⁻¹ to ∼40 keV μm⁻¹. In the frame of heavy ion therapy using carbon, oxygen or neon ions, where LETd increases beyond 100 keV μm⁻¹, helium ions exhibit similar physical attributes such as a sharp lateral penumbra, however, with reduced radio-biological uncertainties and without potentially spoiling dose distributions due to excess fragmentation of heavier ion beams, particularly for higher penetration depths. This roadmap presents an overview of the current state-of-the-art and future directions of helium ion therapy: understanding physics and improving modeling, understanding biology and improving modeling, imaging techniques using helium ions and refining and establishing clinical approaches and aims from learned experience with protons. These topics are organized and presented into three main sections, outlining current and future tasks in establishing clinical and research programs using helium ion beams—A. Physics B. Biological and C. Clinical Perspectives.

Freie Schlagworte: helium ion therapy, medical physics, radiation biology, dosimetry, imaging
Status: Verlagsversion
URN: urn:nbn:de:tuda-tuprints-219061
Sachgruppe der Dewey Dezimalklassifikatin (DDC): 500 Naturwissenschaften und Mathematik > 530 Physik
500 Naturwissenschaften und Mathematik > 570 Biowissenschaften, Biologie
600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin, Gesundheit
Fachbereich(e)/-gebiet(e): 05 Fachbereich Physik
05 Fachbereich Physik > Institut für Physik Kondensierter Materie (IPKM)
Hinterlegungsdatum: 08 Aug 2022 12:03
Letzte Änderung: 09 Aug 2022 06:43
PPN:
Export:
Suche nach Titel in: TUfind oder in Google

Verfügbare Versionen dieses Eintrags

Frage zum Eintrag Frage zum Eintrag

Optionen (nur für Redakteure)
Redaktionelle Details anzeigen Redaktionelle Details anzeigen